NGL Fine Chem P/E Ratio
NGL Fine Chem P/E ratio. NGL Fine Chem (NGLFINE) P/E ratio is 29.4 (High), EPS (TTM) ₹77.90, current price ₹2777.00 on NSE vs historical average P/E of 34.34 (50.0th percentile) — High - Growth expectations or overvalued. Check NGL Fine Chem networth to track the company's total market size over time.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
NGLFINE P/E Ratio — Valuation Signal & Historical Context
NGL Fine Chem P/E 29.4 vs historical average 34.34, range 16.95–62.26 — signal: Overvalued. Also explore NGL Fine Chem share price performance to track price trends across different timeframes.
- Stock appears overvalued with PE of 29.4, suggesting caution for new investments
- Trading at discount to sector average PE of 52.28
NGL Fine Chem P/E Ratio Historical Trend
NGLFINE annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 29.4 vs historical average 34.34. For live price, revenue and the complete fundamental profile, see NGL Fine Chem share price screener.
NGLFINE Historical P/E Ratio — EPS, Year-End Price & Valuation
NGL Fine Chem annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 31.72 | 56.82 | ₹1802.15 | NSE | High |
| 2024 | 40.9 | 52.82 | ₹2160.55 | NSE | High |
| 2023 | 24.81 | 62.06 | ₹1539.75 | NSE | Moderate |
| 2022 | 62.26 | 30.02 | ₹1868.95 | NSE | High |
| 2021 | 29.38 | 91.98 | ₹2702.40 | BSE | High |
| 2019 | 16.95 | 25.05 | ₹424.65 | BSE | Moderate |
NGLFINE vs Healthcare Peers — P/E Ratio Comparison
NGL Fine Chem P/E 29.4 vs Healthcare average 52.28, median 29.6 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |